Non-Hodgkin Lymphoma (NHL)
Non-Hodgkin Lymphoma (NHL) represents a large group of blood cancers originating from lymphocytes.
It can appear in lymph nodes or other organs like the spleen and bone marrow.
New biologic and immunotherapies have improved survival across subtypes.
Overview And Clinical Background
NHL includes indolent and aggressive types based on how fast the cells grow.
The disease disrupts the immune system and blood cell production.
Symptoms, Signs And Presentation
Symptoms depend on the site involved.
General symptoms like fever and weight loss are common.
Diagnosis Methods And Investigations
Imaging And Laboratory Tests
Biopsy confirms diagnosis, while PET-CT determines disease stage and response.
Treatment Options And Surgical Techniques
Treatment varies with subtype and stage.
Most respond well to combined chemoimmunotherapy.
Recovery, Risks And Prognosis
Many patients achieve long-term remission.
Indolent forms may recur but are manageable for years.
Why Choose Us
CureU Healthcare provides hematology experts, access to advanced biologics, and precise staging for tailored lymphoma care.
Conclusion
With new therapies and early diagnosis, Non-Hodgkin Lymphoma has become one of the most treatable blood cancers.
